Description
MRSA REAGENTS FOR LAB @ VAMC, BILOXI, MS.
First action · last action
2012-10-01 · 2014-02-06
Transactions
3
First transaction's obligation
$8,400
Base + all options value (sum of deltas)
$7,120
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P4284B
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-10-01+$8,400= $8,400
- Mod P000012014-01-08-$240= $8,160
- Mod P000022014-02-06-$1,040= $7,120
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-10-01 | +$8,400 | $8,400 | MRSA REAGENTS FOR LAB @ VAMC, BILOXI, MS. |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2014-01-08 | −$240 | $8,160 | MRSA REAGENTS FOR LAB @ VAMC, BILOXI, MS. |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2014-02-06 | −$1,040 | $7,120 | MRSA REAGENTS FOR LAB @ VAMC, BILOXI, MS. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI KBN4ZDJ47ZB9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226N0092 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $7,824 | FY2026 |
| 36C25225P0899 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $200,000 | FY2025 |
| 36C24725P0688 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $36,977 | FY2025 |
| 36C24225C0040 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · J065 · MAINT/REPAIR/REBUILD OF EQUIPMENT- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES | $32,800 | FY2025 |
| 36C24225N0202 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $7,824 | FY2025 |
| 36C25224P1125 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $189,668 | FY2024 |
Other recipients under 6640 from 520-BILOXI (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25613F0155 | FISHER SCIENTIFIC COMPANY L.L.C. | 520-BILOXI | $0 | FY2013 |
| VA25612F2541 | VENTANA MEDICAL SYSTEMS, INC | 520-BILOXI | $117,960 | FY2013 |
| VA25613F0125 | ROCHE DIAGNOSTICS CORPORATION | 520-BILOXI | $23,192 | FY2013 |
| VA25612P2512 | MAINE STANDARDS COMPANY, LLC | 520-BILOXI | $30,772 | FY2013 |
| VA25613P0062 | DAKO NORTH AMERICA, INC. | 520-BILOXI | $358 | FY2013 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25613F0156_3600_V797P4284B_3600 · retrieved 2026-09-26.